In this set of Homerun Slides, we give you a brief overview of the functioning of this new class of drugs, and get into the specifics of the first drug in its class approved by the FDA, canagliflozin (Invokana)…. Link to download (.ppt format): SGLT-2 Inhibitors: A New Modality for Treating …
Read More »Daily Archives: Apr 14, 2013
Core Defects of Type 2 Diabetes, Part 2 of 4
This week’s set of Homerun Slides topics include: The Role of Incretins in Type 2 Diabetes; Non-insulin injection for DM2; and a discussion of the ADOPT study….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Edition, Excerpt #31: Macrovascular Complications, Part 3
Richard S. Beaser, MD Michael Johnstone, MD This week’s excerpt answers the following questions: What are the three disorders of coagulation and fibrinolysis that increase the risk of developing macrovascular disease When and who should be on aspirin therapy How to reduce macrovascular risks Which ACE inhibitor reduces the …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.